AFYA — Afya Limited Stock Price, Chart & AI Report

Positive Oct 7, 2026 • 14:40 UTC Zacks Investment Research • Na

AFYA or UTI: Which Is the Better Value Stock Right Now?

A comparison of two education stocks shows Afya (AFYA) presents a better value opportunity than Universal Technical Institute (UTI). Afya has a stronger Zacks Rank of #2 (Buy) versus UTI's #3 (Hold), and significantly better valuation metrics including a forward P/E of 7.54 compared to UTI's 26.85, earning Afya an A Value grade versus UTI's C grade.

AFYA UTI value investing education stocks valuation metrics P/E ratio Zacks Rank earnings estimates

Sentiment note

Afya demonstrates superior value metrics with a Zacks Rank #2 (Buy), lower forward P/E ratio of 7.54, lower PEG ratio of 1.57, and lower P/B ratio of 1.34, combined with an A Value grade, indicating positive earnings estimate revisions and undervaluation at current price levels.

Positive Oct 7, 2026 • 12:40 UTC Zacks Investment Research • Na

Should Value Investors Buy Afya (AFYA) Stock?

Zacks identifies Afya (AFYA) as an attractive value investment opportunity, citing its Zacks Rank #2 (Buy) rating and 'A' grade for Value. The stock trades at a P/E ratio of 8.67, below its industry average of 10.74, with favorable PEG, P/B, and P/CF ratios suggesting undervaluation relative to its earnings growth prospects.

AFYA value investing stock analysis valuation metrics earnings estimates Zacks Rank

Sentiment note

Afya receives a Zacks Rank #2 (Buy) with an 'A' Value grade. Multiple valuation metrics support a positive outlook: P/E of 8.67 (below industry average of 10.74), PEG ratio of 0.42 (below industry average of 0.72), P/B of 1.81 (below industry average of 3.22), and P/CF of 7.93 (below industry average of 14.28). These metrics collectively indicate the stock is undervalued with strong earnings growth prospects.

Neutral Jul 22, 2024 • 13:00 UTC Zacks Investment Research • Zacks.Com

Zacks Market Edge Highlights: Soundhound AI, Afya, Castle Biosciences, TriMas and Immersion - Zacks Investment Research

The article discusses 5 top small-cap stocks that are Zacks Rank #1 (Strong Buy) or #2 (Buy) stocks, including Soundhound AI, Afya, Castle Biosciences, TriMas, and Immersion. The article provides an overview of each company's business, market cap, stock performance, and earnings growth outlook.

SOUN SOUNW AFYA CSTL small-cap stocks Zacks Rank earnings growth

Sentiment note

The article notes that Afya is the largest hub of education and solutions for medical practice in Brazil, with a market cap of $1.6 billion. While its shares have fallen 19.1% year-to-date, its earnings are expected to rise 27.3% in 2024.

Unknown Jul 2, 2024 • 16:10 UTC Zacks Investment Research • Zacks Equity Research

AFYA Welcomes 300 Operational Medical School Seats in Salvador

AFYA boosts its medical education service offerings by acquiring Unidompedro, which offers 300 operational medical school seats in Salvador.

LZB ATGE AGS AFYA

Unknown Jul 2, 2024 • 11:30 UTC Zacks Investment Research • Zacks Equity Research

Zacks.com featured highlights include Afya, Despegar.com, Kelly Services and Norsk Hydro

Afya, Despegar.com, Kelly Services and Norsk Hydro are part of the Zacks Screen of the Week article.

KELYA NHYDY DESP AFYA

Unknown Jul 1, 2024 • 12:31 UTC Zacks Investment Research • Urmimala Biswas

4 Best GARP Picks for Your Portfolio Based on Discounted PEG

Here are four stocks that perfectly fit our screening criteria based on discounted PEG. They are AFYA, DESP, KELYA and NHYDY.

KELYA NHYDY DESP AFYA

Unknown Jun 28, 2024 • 13:55 UTC Zacks Investment Research • Zacks Equity Research

Wall Street Analysts Think Afya (AFYA) Could Surge 32.79%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 32.8% in Afya (AFYA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

AFYA

Unknown Jun 27, 2024 • 12:32 UTC Zacks Investment Research • Zacks Equity Research

Do Options Traders Know Something About Afya (AFYA) Stock We Don't?

Investors need to pay close attention to Afya (AFYA) stock based on the movements in the options market lately.

AFYA

Unknown Jun 25, 2024 • 13:40 UTC Zacks Investment Research • Zacks Equity Research

Should Value Investors Buy Afya (AFYA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

AFYA

Unknown Jun 14, 2024 • 15:40 UTC Zacks Investment Research • Zacks Equity Research

AFYA vs. BFAM: Which Stock Is the Better Value Option?

AFYA BFAM

Unknown May 9, 2024 • 23:50 UTC Zacks Investment Research • Zacks Equity Research

Afya (AFYA) Tops Q1 Earnings and Revenue Estimates

Afya (AFYA) delivered earnings and revenue surprises of 17.02% and 6.19%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

AFYA TTWO

Unknown May 9, 2024 • 13:10 UTC Zacks Investment Research • Zacks Equity Research

Roblox (RBLX) Reports Q1 Loss, Misses Revenue Estimates

Roblox (RBLX) delivered earnings and revenue surprises of 18.87% and 0.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

RBLX AFYA